Central Nervous System Agents in Medicinal Chemistry
Title:Meet Our Associate Board Member
Volume: 20 Issue: 1
Author(s): Majid Asadi-Shekaari
Affiliation:
Export Options
About this article
Cite this article as:
Asadi-Shekaari Majid, Meet Our Associate Board Member, Central Nervous System Agents in Medicinal Chemistry 2020; 20 (1) . https://dx.doi.org/10.2174/187152492001200303164412
DOI https://dx.doi.org/10.2174/187152492001200303164412 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
15
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of Reactive Oxygen Species in Tumor Necrosis Factor-alpha Induced Endothelial Dysfunction
Current Hypertension Reviews The Use of the Zebrafish Model to Aid in Drug Discovery and Target Validation
Current Topics in Medicinal Chemistry From Surface to Nuclear Receptors: The Endocannabinoid Family Extends its Assets
Current Medicinal Chemistry Pharmacology of Cyclic Peptides: Vancomycin and Oxytocin as Paradigms
Protein & Peptide Letters Radiopharmaceutical Chemistry with Iodine-124: A Non-Standard Radiohalogen for Positron Emission Tomography
Medicinal Chemistry A Discussion of MicroRNAs in Cancers
Current Bioinformatics The CSF p-tau181/Aβ42 Ratio Offers a Good Accuracy “In Vivo” in the Differential Diagnosis of Alzheimer’s Dementia
Current Alzheimer Research Potential Applications of Hydrogen Sulfide-Induced Suspended Animation
Current Medicinal Chemistry PET Imaging of Opioid Receptors in Pain: Progress and New Directions
Current Pharmaceutical Design The Possibilities and Pitfalls for Anti-Complement Therapies in Inflammatory Diseases
Current Drug Targets - Inflammation & Allergy Acute and Chronic Stress-Induced Disturbances of Microglial Plasticity, Phenotype and Function
Current Drug Targets Biochemical Differentiation of Cholinesterases from Normal and Alzheimers Disease Cortex
Current Alzheimer Research Unsuspected Intrinsic Property of Melanin to Dissociate Water Can Be Used for the Treatment of CNS Diseases
CNS & Neurological Disorders - Drug Targets Modeling Rett Syndrome Using Human Induced Pluripotent Stem Cells
CNS & Neurological Disorders - Drug Targets Current Role of Proteomics in Pancreatic Cancer Biomarkers Research
Current Proteomics The Menstrual Cycle and Drug Metabolism
Current Drug Metabolism mGluRI Targets Microglial Activation and Selectively Prevents Neuronal Cell Engulfment Through Akt and Caspase Dependent Pathways
Current Neurovascular Research Phosphodiesterase-4 Modulation as a Potential Therapeutic for Cognitive Loss in Pathological and Non-Pathological Aging: Possibilities and Pitfalls
Current Pharmaceutical Design Enzyme Inhibitory Effect and Antioxidant Properties of Astragalus lagurus Extracts
Current Enzyme Inhibition Daily Melatonin Administration Attenuates Age-Dependent Disturbances of Cardiovascular Rhythms
Current Aging Science